Nurix Therapeutics, Inc. Quarterly Assets in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Nurix Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2019 to Q3 2024.
  • Nurix Therapeutics, Inc. Assets for the quarter ending August 31, 2024 was $514M, a 66.6% increase year-over-year.
Assets, Quarterly (USD)
Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $514M +$205M +66.6% Aug 31, 2024 10-Q 2024-10-11
Q2 2024 $511M +$160M +45.7% May 31, 2024 10-Q 2024-07-11
Q1 2024 $313M -$57.5M -15.5% Feb 29, 2024 10-Q 2024-04-10
Q4 2023 $356M -$61.2M -14.7% Nov 30, 2023 10-Q 2024-10-11
Q3 2023 $308M -$151M -32.9% Aug 31, 2023 10-Q 2023-10-12
Q2 2023 $351M -$43.7M -11.1% May 31, 2023 10-Q 2023-07-13
Q1 2023 $370M -$67.6M -15.4% Feb 28, 2023 10-Q 2023-04-13
Q4 2022 $417M -$60M -12.6% Nov 30, 2022 10-K 2024-02-15
Q3 2022 $459M -$33.7M -6.84% Aug 31, 2022 10-Q 2022-10-06
Q2 2022 $394M -$124M -23.9% May 31, 2022 10-Q 2022-07-07
Q1 2022 $438M +$41.1M +10.4% Feb 28, 2022 10-Q 2022-04-08
Q4 2021 $477M +$80.4M +20.3% Nov 30, 2021 10-K 2023-02-09
Q3 2021 $493M +$81.2M +19.7% Aug 31, 2021 10-Q 2021-10-14
Q2 2021 $518M May 31, 2021 10-Q 2021-07-13
Q1 2021 $397M Feb 28, 2021 10-Q 2021-04-13
Q4 2020 $396M +$352M +800% Nov 30, 2020 10-K 2022-01-28
Q3 2020 $412M Aug 31, 2020 10-Q 2020-10-14
Q4 2019 $44M Nov 30, 2019 10-K 2021-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.